Pancreatic Cancer Research

ResearcherYonsei UniversityActive in the last 2 years

Dong Ki Lee

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-0048-9112; OpenAlex author ID A5074471138. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
48
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 2 papers · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: 3 papers · 2024: 1 paper · 2025: 1 paper

Papers 14

  1. A New Staining Method Using Methionyl-tRNA Synthetase 1 Antibody for Endoscopic Ultrasound-Guided Fine-Needle Aspiration Cytology of Pancreatic Cancer. Last author DOI 10.3390/diagnostics15141783↗
  2. Tumour-associated myeloid cells expressing IL-10R2/IL-22R1 as a potential biomarker for diagnosis and recurrence of pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41416-024-02676-w↗
  3. Development of a metabolite calculator for diagnosis of pancreatic cancer. Co-author DOI 10.1002/cam4.6233↗
  4. Improved predictability of pancreatic ductal adenocarcinoma diagnosis using a blood immune cell biomarker panel developed from bulk mRNA sequencing and single-… Last author DOI 10.1007/s00262-023-03458-8↗
  5. Prediction of Prognosis in Pancreatic Cancer According to Methionyl-tRNA Synthetase 1 Expression as Determined by Immunohistochemical Staining. Last author DOI 10.3390/cancers15225413↗
  6. Identification of circulating myeloid cells as a potential diagnosis and recurrence marker of pancreatic ductal adenocarcinoma through the single-cell analysis Last author DOI 10.21203/rs.3.rs-2345667/v1↗
  7. Validation of IL-7R as an Immunological Biomarker for Human Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/cancers14030853↗
  8. Characterization of Circulating IL-7R Positive Cell Populations for Early Detection of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/jcm10184157↗
  9. Inhibition of MUC1 biosynthesis via threonyl-tRNA synthetase suppresses pancreatic cancer cell migration. Co-author DOI 10.1038/emm.2017.231↗
  10. A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-line chemotherapy for advanced pancreati… Co-author DOI 10.1097/md.0000000000005702↗
  11. Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer. Co-author DOI 10.18632/oncotarget.10323↗
  12. Prognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma. Co-author DOI 10.4143/crt.2015.400↗
  13. Gemcitabine Combined with Capecitabine Compared to Gemcitabine with or without Erlotinib as First-Line Chemotherapy in Patients with Advanced Pancreatic Cancer. Co-author DOI 10.4143/crt.2013.158↗
  14. Collagen triple helix repeat containing-1 promotes pancreatic cancer progression by regulating migration and adhesion of tumor cells. Co-author DOI 10.1093/carcin/bgs378↗

Closest collaborators

The 25 strongest of 48 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sung Ill Jang · 8 shared papers, 2021–2025 · strength 1.36
  2. Hyung Keun Lee · 5 shared papers, 2021–2024 · strength 0.78
  3. Jae Hee Cho · 4 shared papers, 2022–2025 · strength 0.71
  4. Joon Seong Park · 5 shared papers, 2016–2024 · strength 0.69
  5. Eun‐Ju Chang · 4 shared papers, 2021–2024 · strength 0.63
  6. Sung‐Hoon Kim · 2 shared papers, 2018–2023 · strength 0.25
  7. Jin Hong Lim · 1 shared paper, 2025 · strength 0.22
  8. Jung Hyun Jo · 1 shared paper, 2025 · strength 0.22
  9. Hyung Sun Kim · 1 shared paper, 2025 · strength 0.22
  10. Min Jung Lee · 1 shared paper, 2023 · strength 0.18
  11. Munseok Choi · 1 shared paper, 2023 · strength 0.18
  12. Sung Hwan Lee · 1 shared paper, 2023 · strength 0.18
  13. Chang Moo Kang · 1 shared paper, 2023 · strength 0.18
  14. Young‐Ki Paik · 1 shared paper, 2023 · strength 0.18
  15. Sun‐Hee Heo · 1 shared paper, 2021 · strength 0.15
  16. Dong Sup Yoon · 2 shared papers, 2015–2016 · strength 0.12
  17. Si Young Song · 2 shared papers, 2013–2017 · strength 0.09
  18. Seung Jae Jeong · 1 shared paper, 2018 · strength 0.08
  19. Jae Yun Lim · 1 shared paper, 2015 · strength 0.06
  20. Y. Choi · 1 shared paper, 2015 · strength 0.06
  21. Min Goo Lee · 1 shared paper, 2016 · strength 0.06
  22. Hei‐Cheul Jeung · 1 shared paper, 2016 · strength 0.06
  23. Hyung Soon Park · 1 shared paper, 2016 · strength 0.06
  24. Shouhui Yang · 1 shared paper, 2016 · strength 0.05
  25. Nader N Hanna · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.